Currently, less than 5% of government funding for medical research goes into surgery
One of only 7 Royal College of Surgeons specialist trial centres across the whole of the UK, SITU is a collaboration between the Nuffield Department of Surgical Sciences (NDS) and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS). We have an extensive portfolio of surgical trials and welcome expressions of interest from potential new researchers.
©
SITU
More information about NDS SITU and our work within surgical research can be found by following the links below.
About Us
Our Surgical Trials
Work With Us
The NDS SITU team
-
Michael Douek
The Rosetrees Royal College of Surgeons of England Director of SITU
-
-
Nadjat Medeghri
SITU Operational Lead
-
-
-
Amy Jones
FUTURE-GB Trial Manager
-
-
Charles Malyon
Clinical Trial Manager
-
-
Parisa Sinai
Clinical Trial Manager – DISCUS
-
-
-
-
Katherine De Wilde
Clinical Data Coordinator
-
Jack Morris
MACRO Clinical Trial Coordinator
Latest publications
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Journal article
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
-
Exercise therapy with or without other physical therapy interventions versus placebo interventions for osteoarthritis –systematic review
Journal article
DEAN B. et al, (2021), Osteoarthritis and Cartilage Open
-
Preservation of the intercostobrachial nerve during axillary node clearance for breast cancer
Journal article
Ahmed M. et al, (2021), Cochrane Database of Systematic Reviews, 2021
-
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Journal article
Vaidya JS. et al, (2021), Br J Cancer